https://www.justajournals.com/
Latest
New target for drug development could fill a major gap in depression treatment - News-Medical.net
Health Mon Nov 15 2021

New target for drug development could fill a major gap in depression treatment - News-Medical.net

News-Medical.Net
THE IDEA Vanderbilt researchers found that ketamine's rapid antidepressant action is due to specific synaptic effects. This represents a new target for drug development that could fill a major gap i… [+2414 chars] Vanderbilt researchers found that ketamine's rapid antidepressant action is due to specific synaptic effects. Read More
Related